| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9846 |
| Human Intestinal Absorption | HIA+ | 0.9969 |
| Caco-2 Permeability | Caco2+ | 0.7977 |
| P-glycoprotein Substrate | Substrate | 0.6041 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.6769 |
| Non-inhibitor | 0.9583 |
| Renal Organic Cation Transporter | Inhibitor | 0.6430 |
| Distribution |
| Subcellular localization | Mitochondria | 0.4517 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8398 |
| CYP450 2D6 Substrate | Substrate | 0.6133 |
| CYP450 3A4 Substrate | Substrate | 0.6142 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.7819 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9346 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.6649 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.6534 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.8458 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8231 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.7016 |
| Non-inhibitor | 0.7799 |
| AMES Toxicity | Non AMES toxic | 0.8256 |
| Carcinogens | Non-carcinogens | 0.9313 |
| Fish Toxicity | Low FHMT | 0.7948 |
| Tetrahymena Pyriformis Toxicity | Low TPT | 0.6544 |
| Honey Bee Toxicity | Low HBT | 0.8119 |
| Biodegradation | Not ready biodegradable | 0.9087 |
| Acute Oral Toxicity | III | 0.4934 |
| Carcinogenicity (Three-class) | Non-required | 0.5560 |